2AA-44772-90054

3 vaccinations 5 coded responses 19 check-ins 5 free-text entries 5 call cases

Sex: Female
Age at first dose: 61-65
ZIP prefix: 210 / MD
Registered: 2021-01-17

Relationship: Self
Race: White
Ethnicity: Not Hispanic or Latino

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-01-17
Registered in v-safe
2021-01-17
Dose 1 — Pfizer-BioNTech
2021-01-17
Survey response — day 0, dose 1
MedDRA: Dizziness — Feeling: Fair · Site: Pain · Fever · Fatigue or tiredness · Be unable to do your normal daily activities

Free text: Light headed, dizzy

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-01-17
Report sent to call center — day 0, dose 1
Be unable to do your normal daily activities

1 call case(s)
2021-01-18
Health check-in — days 1–6 daily, dose 1
Feeling: Fair · Site: Pain · Fatigue or tiredness · Be unable to do your normal daily activities

Adult check-in
2021-01-18
Report sent to call center — days 1–6 daily, dose 1
Be unable to do your normal daily activities

1 call case(s)
2021-01-21
Health check-in — days 1–6 daily, dose 1
Feeling: Good · Fatigue or tiredness

Adult check-in
2021-01-22
Health check-in — days 1–6 daily, dose 1
Feeling: Good · None

Adult check-in
2021-01-23
Health check-in — days 1–6 daily, dose 1
Feeling: Good · None

Adult check-in
2021-01-24
Health check-in — day 7, dose 1
Feeling: Good · None

Adult check-in
2021-01-31
Survey response — day 14, dose 1
MedDRA: Blood test abnormal, Muscle rigidity, Pain in extremity — Feeling: Poor · Be unable to work, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Emergency room or emergency department visit, Hospitalization

Free text: Severe pain in both legs with severe rigidity of both legs. Bloodwork indicates muscle breakdown or trauma. Undergoing inpatient testing; doctors are baffled.

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-01-31
Report sent to call center — day 14, dose 1
Be unable to work · Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional

1 call case(s)
2021-02-07
Survey response — day 21, dose 1
MedDRA: Adverse drug reaction, Hospitalisation — Feeling: Poor · Be unable to work, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Emergency room or emergency department visit, Hospitalization

Free text: Severe reaction to one dose of the statin Crestor. Required admission to hospital for 3 days.

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-02-07
Report sent to call center — day 21, dose 1
Be unable to work · Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional

1 call case(s)
2021-02-11
Dose 2 — Pfizer-BioNTech
2021-02-23
Health check-in — day 7, dose 2
Feeling: Good · None

Adult check-in
2021-02-25
Health check-in — day 14, dose 2
Feeling: Good

Adult check-in
2021-03-04
Health check-in — day 21, dose 2
Feeling: Good

Adult check-in
2021-03-11
Survey response — day 28, dose 2
MedDRA: Diarrhoea, Headache, Nausea, Pain — Feeling: Good · Be unable to work, Be unable to do your normal daily activities

Free text: Diarrhea, nausea, headache, achy

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-03-18
Health check-in — day 35, dose 2
Feeling: Good

Adult check-in
2021-03-25
Health check-in — day 42, dose 2
Feeling: Good

Adult check-in
2021-05-13
Health check-in — 3 months, dose 2
Feeling: Good

Adult check-in
2021-06-14
Call 1 — Left Voicemail
2021-08-12
Health check-in — 6 months, dose 2
Feeling: Good

Adult check-in
2021-09-04
Dose 3 — Pfizer-BioNTech
2022-02-14
Survey response — 12 months, dose 2
MedDRA: Ageusia, Anosmia, COVID-19, Cough, Diarrhoea, Dyspnoea, Headache, Mobility decreased, Myalgia, Oropharyngeal pain, Pyrexia — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit

Free text: Dx with COVID 11/22/21. Received monoclonal antibody infusion on 11/23/21. Symptoms: fever, severe myalgia, cough, sore throat, severe headache, diarrhea, trouble breathing, loss taste and smell (returning sporadically at this point). In bed 10 da

MedDRA releases: 2024-11 · check-in free text available
2022-02-14
Report sent to call center — 12 months, dose 2
Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr

Outpatient clinic or urgent care clinic visit · 1 call case(s)
2022-02-16
Call 1 — Left Voicemail
2022-03-07
Health check-in — 6 months, dose 3
Feeling: Good

Adult check-in
2022-09-04
Health check-in — 12 months, dose 3
Feeling: Good

Adult check-in

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-01-17	Pfizer-BioNTech
2	2021-02-11	Pfizer-BioNTech
3	2021-09-04	Pfizer-BioNTech	No

Call center

5 call center cases

3 unsuccessful · 2 priority 2/3 (triaged and no follow up)

1 wait over 3 months for a first call

See the call center timeline

Free text

Release 2 — day 0, dose 1

2021-01-17

Systemic reaction (other): Light headed, dizzy

Release 3 — day 14, dose 1

2021-01-31

Symptoms: Severe pain in both legs with severe rigidity of both legs. Bloodwork indicates muscle breakdown or trauma. Undergoing inpatient testing; doctors are baffled.

Release 3 — day 21, dose 1

2021-02-07

Symptoms: Severe reaction to one dose of the statin Crestor. Required admission to hospital for 3 days.

Release 5 — day 28, dose 2

2021-03-11

Symptoms: Diarrhea, nausea, headache, achy

Release 11 — 12 months, dose 2

2022-02-14

Symptoms: Dx with COVID 11/22/21. Received monoclonal antibody infusion on 11/23/21. Symptoms: fever, severe myalgia, cough, sore throat, severe headache, diarrhea, trouble breathing, loss taste and smell (returning sporadically at this point). In bed 10 da

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	Adverse drug reaction	✓	✓	✓
SD	Ageusia	·	·	✓
SD	Anosmia	·	·	✓
SD	Blood test abnormal	✓	✓	✓
SD	Cough	·	·	✓
SD	COVID-19	·	·	✓
SD	Diarrhoea	✓	✓	✓
SD	Dyspnoea	·	·	✓
SD	Headache	✓	✓	✓
SD	Hospitalisation	✓	✓	✓
SD	Mobility decreased	·	·	✓
SD	Muscle rigidity	✓	✓	✓
SD	Myalgia	·	·	✓
SD	Nausea	✓	✓	✓
SD	Oropharyngeal pain	·	·	✓
SD	Pain	✓	✓	✓
SD	Pain in extremity	✓	✓	✓
SD	Pyrexia	·	·	✓
SRO	Dizziness	✓	✓	✓

✓ active code · ○ coded but marked inactive · blank = not in that release